{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:59:13Z","timestamp":1787032753611,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,23]]},"DOI":"10.7759\/cureus.111383","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T21:56:54Z","timestamp":1782251814000},"source":"Crossref","is-referenced-by-count":1,"title":["Coexistence of Elevated Mean Platelet Volume and Bleeding Symptoms in Chronic Kidney Disease: A Discordant Hemostatic Profile"],"prefix":"10.7759","author":[{"given":"Ayomide","family":"Adeyeye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tehzeeb","family":"Abdul Sattar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaushalendra","family":"Mani Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahil","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul Sunday","family":"Samuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GKM Rashik","family":"Uzzaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayodeji","family":"Oso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud AM","family":"Abughazal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibgha","family":"Shreen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2020101440","article-title":"Platelet function in CKD: a systematic review and meta-analysis","volume":"32","author":"Baaten CC","year":"2021","unstructured":"Baaten CC, Sternkopf M, Henning T, Marx N, Jankowski J, Noels H. Platelet function in CKD: a systematic review and meta-analysis. J Am Soc Nephrol. 2021, 32:1583-98. 10.1681\/ASN.2020101440","journal-title":"J Am Soc Nephrol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.5222\/terh.1994.52735","article-title":"Uremic bleeding: a concise review","volume":"4","author":"Salman S","year":"1994","unstructured":"Salman S. Uremic bleeding: a concise review. J Tepecik Educ Res Hosp. 1994, 4:7-13. 10.5222\/terh.1994.52735","journal-title":"J Tepecik Educ Res Hosp"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25168705","article-title":"Hallmarks for thrombotic and hemorrhagic risks in chronic kidney disease patients","volume":"25","author":"Saeed Z","year":"2024","unstructured":"Saeed Z, Sirolli V, Bonomini M, Gallina S, Renda G. Hallmarks for thrombotic and hemorrhagic risks in chronic kidney disease patients. Int J Mol Sci. 2024, 25:8705. 10.3390\/ijms25168705","journal-title":"Int J Mol Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2025017625","article-title":"Platelet dysfunction in chronic kidney disease arises from bone marrow remodeling and megakaryocyte reprogramming","volume":"10","author":"Carminita E","year":"2026","unstructured":"Carminita E, Camacho V, Branfield S, et al.. Platelet dysfunction in chronic kidney disease arises from bone marrow remodeling and megakaryocyte reprogramming. Blood Adv. 2026, 10:1444-56. 10.1182\/bloodadvances.2025017625","journal-title":"Blood Adv"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2022.07.169","article-title":"Platelet activity and cardiovascular risk in CKD and peripheral artery disease","volume":"7","author":"Cofer LB","year":"2022","unstructured":"Cofer LB, Soomro QH, Xia Y, Luttrell-Williams E, Myndzar K, Charytan DM, Berger JS. Platelet activity and cardiovascular risk in CKD and peripheral artery disease. Kidney Int Rep. 2022, 7:2242-50. 10.1016\/j.ekir.2022.07.169","journal-title":"Kidney Int Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2017.08.039","article-title":"The hypercoagulability paradox of chronic kidney disease: the role of fibrinogen","volume":"214","author":"Nunns GR","year":"2017","unstructured":"Nunns GR, Moore EE, Chapman MP, et al.. The hypercoagulability paradox of chronic kidney disease: the role of fibrinogen. Am J Surg. 2017, 214:1215-8. 10.1016\/j.amjsurg.2017.08.039","journal-title":"Am J Surg"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18903","article-title":"Navigating through the haemostatic paradox in kidney failure: a practical overview","volume":"202","author":"Caruana J","year":"2023","unstructured":"Caruana J, Riva N, Vella K, Davenport A, Gatt A. Navigating through the haemostatic paradox in kidney failure: a practical overview. Br J Haematol. 2023, 202:230-47. 10.1111\/bjh.18903","journal-title":"Br J Haematol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/life16040547","article-title":"Inflammation, endothelial dysfunction, and platelet dysregulation in atrial fibrillation with chronic kidney disease: toward a biology-informed anticoagulation strategy","volume":"16","author":"Tanasescu MD","year":"2026","unstructured":"Tanasescu MD, Rosu AM, Minca A, Grigorie MM, Timofte D, Ionescu D. Inflammation, endothelial dysfunction, and platelet dysregulation in atrial fibrillation with chronic kidney disease: toward a biology-informed anticoagulation strategy. Life. 2026, 16:547. 10.3390\/life16040547","journal-title":"Life"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2020121806","article-title":"Role of platelets in chronic kidney disease","volume":"32","author":"Jain N","year":"2021","unstructured":"Jain N, Corken AL, Kumar A, Davis CL, Ware J, Arthur JM. Role of platelets in chronic kidney disease. J Am Soc Nephrol. 2021, 32:1551-8. 10.1681\/ASN.2020121806","journal-title":"J Am Soc Nephrol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1055\/s-0045-1809162","article-title":"Global hemostasis testing in chronic kidney disease: are they better predictors of bleeding and thrombosis risk?","volume":"52","author":"Lim HY","year":"2026","unstructured":"Lim HY, Yap ES, Ho P. Global hemostasis testing in chronic kidney disease: are they better predictors of bleeding and thrombosis risk?. Semin Thromb Hemost. 2026, 52:391-404. 10.1055\/s-0045-1809162","journal-title":"Semin Thromb Hemost"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms27031359","article-title":"Influence of chronic kidney disease on platelet reactivity response to clopidogrel and ticagrelor","volume":"27","author":"Franci A","year":"2026","unstructured":"Franci A, Giraldez R, Barbosa C, et al.. Influence of chronic kidney disease on platelet reactivity response to clopidogrel and ticagrelor. Int J Mol Sci. 2026, 27:1359. 10.3390\/ijms27031359","journal-title":"Int J Mol Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-022-01694-7","article-title":"Sample size calculation for prevalence studies using Scalex and ScalaR calculators","volume":"22","author":"Naing L","year":"2022","unstructured":"Naing L, Nordin RB, Abdul Rahman H, Naing YT. Sample size calculation for prevalence studies using Scalex and ScalaR calculators. BMC Med Res Methodol. 2022, 22:209. 10.1186\/s12874-022-01694-7","journal-title":"BMC Med Res Methodol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/kisup.2012.76","article-title":"Kidney disease: improving global outcomes (KDIGO) CKD Work Group: KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","year":"2013","unstructured":"Kidney disease. improving global outcomes (KDIGO) CKD Work Group: KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Inter Suppl. 2013, 3:1-150. 10.1038\/kisup.2012.76","journal-title":"Kidney Inter Suppl"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/mbc.0000000000000717","article-title":"Mean platelet volume and risk of thrombotic and bleeding complications in patients with Philadelphia chromosome negative myeloproliferative neoplasms","volume":"29","author":"Krashin E","year":"2018","unstructured":"Krashin E, Cohen O, Pereg D, Lishner M, Leader A. Mean platelet volume and risk of thrombotic and bleeding complications in patients with Philadelphia chromosome negative myeloproliferative neoplasms. Blood Coagul Fibrinolysis. 2018, 29:288-93. 10.1097\/mbc.0000000000000717","journal-title":"Blood Coagul Fibrinolysis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0260439","article-title":"Baseline mean platelet volume is a strong predictor of major and life-threatening bleedings after transcatheter aortic valve replacement","volume":"16","author":"Trimaille A","year":"2021","unstructured":"Trimaille A, Matsushita K, Marchandot B, et al.. Baseline mean platelet volume is a strong predictor of major and life-threatening bleedings after transcatheter aortic valve replacement. PLoS One. 2021, 16:e0260439. 10.1371\/journal.pone.0260439","journal-title":"PLoS One"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3109\/09537104.2014.890179","article-title":"Could mean platelet volume be a promising biomarker of progression of chronic kidney disease?","volume":"26","author":"Ju HY","year":"2015","unstructured":"Ju HY, Kim JK, Hur SM, et al.. Could mean platelet volume be a promising biomarker of progression of chronic kidney disease?. Platelets. 2015, 26:143-7. 10.3109\/09537104.2014.890179","journal-title":"Platelets"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1041356","article-title":"Association of mean platelet volume\/lymphocyte ratio with inflammation in non-dialysis patients with chronic kidney disease stages 1-4: a retrospective study","volume":"13","author":"Xu B","year":"2022","unstructured":"Xu B, Zhang Y, Chen G, Feng J, Gan L. Association of mean platelet volume\/lymphocyte ratio with inflammation in non-dialysis patients with chronic kidney disease stages 1-4: a retrospective study. Front Immunol. 2022, 13:1041356. 10.3389\/fimmu.2022.1041356","journal-title":"Front Immunol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2020.01.068","article-title":"Increased mean platelet volume is associated with poor outcome in patients with aneurysmal subarachnoid hemorrhage","volume":"137","author":"Chen L","year":"2020","unstructured":"Chen L, Zhang Q. Increased mean platelet volume is associated with poor outcome in patients with aneurysmal subarachnoid hemorrhage. World Neurosurg. 2020, 137:118-25. 10.1016\/j.wneu.2020.01.068","journal-title":"World Neurosurg"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/biom11091309","article-title":"Coagulation abnormalities in renal pathology of chronic kidney disease: the interplay between blood cells and soluble factors","volume":"11","author":"Pavlou EG","year":"2021","unstructured":"Pavlou EG, Georgatzakou HT, Fortis SP, et al.. Coagulation abnormalities in renal pathology of chronic kidney disease: the interplay between blood cells and soluble factors. Biomolecules. 2021, 11:1309. 10.3390\/biom11091309","journal-title":"Biomolecules"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2022.11.020","article-title":"Gender differences in clinical outcomes after percutaneous coronary intervention: analysis of 15,106 patients from the cardiac registry of Pakistan database","volume":"188","author":"Peerwani G","year":"2023","unstructured":"Peerwani G, Khan SM, Khan MD, et al.. Gender differences in clinical outcomes after percutaneous coronary intervention: analysis of 15,106 patients from the cardiac registry of Pakistan database. Am J Cardiol. 2023, 188:61-7. 10.1016\/j.amjcard.2022.11.020","journal-title":"Am J Cardiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2021.05.016","article-title":"Female sex as an independent predictor of high bleeding risk among East Asian percutaneous coronary intervention patients: a sex difference analysis","volume":"78","author":"Kodaira M","year":"2021","unstructured":"Kodaira M, Sawano M, Tanaka M, et al.. Female sex as an independent predictor of high bleeding risk among East Asian percutaneous coronary intervention patients: a sex difference analysis. J Cardiol. 2021, 78:431-8. 10.1016\/j.jjcc.2021.05.016","journal-title":"J Cardiol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2016.03.018","article-title":"Impact of renal function on mean platelet volume and its relationship with coronary artery disease: a single-centre cohort study","volume":"141","author":"Verdoia M","year":"2016","unstructured":"Verdoia M, Barbieri L, Schaffer A, Bellomo G, Marino P, De Luca G. Impact of renal function on mean platelet volume and its relationship with coronary artery disease: a single-centre cohort study. Thromb Res. 2016, 141:139-44. 10.1016\/j.thromres.2016.03.018","journal-title":"Thromb Res"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-017-0175-5","article-title":"Age differences in diabetes-related complications and glycemic control","volume":"17","author":"Shamshirgaran SM","year":"2017","unstructured":"Shamshirgaran SM, Mamaghanian A, Aliasgarzadeh A, Aiminisani N, Iranparvar-Alamdari M, Ataie J. Age differences in diabetes-related complications and glycemic control. BMC Endocr Disord. 2017, 17:25. 10.1186\/s12902-017-0175-5","journal-title":"BMC Endocr Disord"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-017-1473-5","article-title":"Diabetes mellitus is associated with increased bleeding in pulmonary embolism receiving conventional anticoagulant therapy: findings from a real-world study","volume":"43","author":"Zhang Z","year":"2017","unstructured":"Zhang Z, Zhai Z, Yang Y, et al.. Diabetes mellitus is associated with increased bleeding in pulmonary embolism receiving conventional anticoagulant therapy: findings from a real-world study. J Thromb Thrombolysis. 2017, 43:540-9. 10.1007\/s11239-017-1473-5","journal-title":"J Thromb Thrombolysis"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1080\/00015385.2021.1882111","article-title":"Risk of stroke and bleeding in relation to hypertension in anticoagulated patients with atrial fibrillation: a meta-analysis of randomized controlled trials","volume":"77","author":"Harskamp RE","year":"2022","unstructured":"Harskamp RE, Lucassen WA, Lopes RD, Himmelreich JL, Parati G, van Weert HC. Risk of stroke and bleeding in relation to hypertension in anticoagulated patients with atrial fibrillation: a meta-analysis of randomized controlled trials. Acta Cardiol. 2022, 77:191-5. 10.1080\/00015385.2021.1882111","journal-title":"Acta Cardiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/496561-coexistence-of-elevated-mean-platelet-volume-and-bleeding-symptoms-in-chronic-kidney-disease-a-discordant-hemostatic-profile","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T21:56:55Z","timestamp":1782251815000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/496561-coexistence-of-elevated-mean-platelet-volume-and-bleeding-symptoms-in-chronic-kidney-disease-a-discordant-hemostatic-profile"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.111383","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,23]]}}}